TME Pharma NV collaboration news – TME Pharma NV Collaboration with Aimed Analytics

This partnership supports TME Pharma ’s plan , announced on December 4, 2024, by strengthening its positioning and capabilities in the eyes of potential strategic partners.

Read also - Wingbits Funding News- Sweden- based Wingbits Raises €5.3Mn to Transform Flight Tracking

The partnership aims to use artificial intelligence (AI) to ultimately create new and improved drug candidates without laboratory testing. The collaboration leverages recent cutting-edge advances in AI to accelerate timelines while reducing associated costs and the need for experimental infrastructure.

Aram Mangasarian, CEO of TME Pharma said, “The 2024 Nobel Prize in Chemistry was awarded to AI-based models that enable remarkable prediction of molecular structures. This technology can also be used to discover new drugs and improved versions of existing drugs. We believe that the collaboration with aimed analytics will advance our strategic vision announced last December. By combining our expertise in oligonucleotide drug development, cancer biology and immuno-oncology with the cutting-edge capabilities of aimed analytics, we aim to integrate AI-based insights and deep learning into drug discovery capabilities , The goal of this collaboration is to enable TME Pharma to bring not only its existing drugs to the table of strategic partners, but also the potential for rapid and efficient discovery of new drugs. We are committed to achieving the goals of our new strategy announced in December 2024 and plan to share further information on our progress in the coming weeks.”

Dr. Patrick Günther, CEO of aimed analytics said, “We are excited to partner with TME Pharma and bring our expertise in deep learning and structural modeling to their innovative approach to cancer treatment, By enabling a comprehensive search for promising therapeutic compounds and bringing a new level of technological sophistication to TME Pharma ’s drug discovery efforts , we aim to accelerate the discovery of more effective treatments and potentially lead to breakthrough therapies for patients in need.”

About Aimed Analytics

aimed analytics, a pioneer in AI-powered data analytics, drives innovation in pharmaceutical research and development through its innovative data analytics platform and the application of advanced deep learning models for structural prediction. By integrating cutting-edge AI technologies with its expertise in omics data analysis, aimed analytics enables researchers to uncover insights that accelerate drug discovery and development.

About TME Pharma

TME Pharma is a clinical-stage company focused on developing novel therapies for the treatment of the most aggressive cancers. TME Pharma's oncology product portfolio aims to act on the tumor microenvironment and the cancer immune cycle by breaking down the tumor's protective barriers against the patient's immune system and blocking tumor repair.